Zai Lab Limited
Hong Kong Stock ExchangeTotal Valuation
Zai Lab Limited carries a market capitalization of 15.03B, placing it among publicly traded companies globally. Its enterprise value stands at 1.50B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 15.03B |
| Enterprise Value | 1.50B |
Share Statistics
Zai Lab Limited currently has 1.11B shares outstanding.
| Shares Outstanding | 1.11B |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 4.25, and the price-to-book ratio stands at -0.72.
| PE Ratio | N/A |
| PS Ratio | 4.25 |
| PB Ratio | -0.72 |
| P/TBV Ratio | 3.30 |
| P/FCF Ratio | -27.84 |
| P/OCF Ratio | -19.06 |
Enterprise Valuation
| EV / Sales | 3.30 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Financial Position
Zai Lab Limited maintains a current ratio of 2.40, meaning it holds 2.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 35.03, indicating elevated leverage, while an interest coverage ratio of -39.06 demonstrates limited ability to service its debt obligations.
| Current Ratio | 2.40 |
| Quick Ratio | 1.84 |
| Debt / Equity | 35.03 |
| Debt / EBITDA | -1.05 |
| Interest Coverage | -39.06 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -15.70 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.74 |
Taxes
| Income Tax | -1.49M |
| Effective Tax Rate | N/A |
Stock Price Statistics
Zai Lab Limited's stock has declined approximately -58.01887% over the past 52 weeks. The 50-day moving average sits at 15.61, while the 200-day moving average is 17.19.
| Beta (5Y) | N/A |
| 52-Week Price Change | -58.01887% |
| 50-Day Moving Average | 15.61 |
| 200-Day Moving Average | 17.19 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Zai Lab Limited generated 453.28M in revenue and converted that into -178.11M in net income, yielding earnings per share of -0.16. EBITDA reached -221.06M, while operating income came in at -236.56M.
| Revenue | 453.28M |
| Gross Profit | 262.51M |
| Operating Income | -236.56M |
| Pretax Income | -179.60M |
| Net Income | -178.11M |
| EBITDA | -221.06M |
| EBIT | -236.56M |
| Earnings Per Share (EPS) | -0.16 |
Balance Sheet
Zai Lab Limited holds 661.32M in cash and equivalents against 231.91M in total debt, resulting in a net debt position of -437.50M. Total book value stands at -2.68B, with working capital of 551.75M providing operational flexibility.
| Cash & Cash Equivalents | 661.32M |
| Total Debt | 231.91M |
| Net Debt | -437.50M |
| Equity (Book Value) | -2.68B |
| Book Value Per Share | -2.43 |
| Working Capital | 551.75M |
Cash Flow
Zai Lab Limited produced -101.00M in operating cash flow over the past twelve months. After subtracting -31.85M in capital expenditures, free cash flow totaled -132.85M - equivalent to -0.12 per share.
| Operating Cash Flow | -101.00M |
| Capital Expenditures | -31.85M |
| Free Cash Flow | -132.85M |
| FCF Per Share | -0.12 |
Margins
Zai Lab Limited operates with a gross margin of 57.91, reflecting its pricing power and cost economics. The operating margin of -52.19 and net profit margin of -39.29 provide insight into operational efficiency.
| Gross Margin | 57.91 |
| Operating Margin | -52.19 |
| Pretax Margin | -39.62 |
| Profit Margin | -39.29 |
| EBITDA Margin | -48.77 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -1.81 |
| FCF Yield | -3.59 |
Stock Splits
Zai Lab Limited's most recent stock split took place on March 30, 2022 with a 1:10 split ratio.
| Last Split Date | 3/30/2022 |
| Split Ratio | 1:10 |
Scores
Zai Lab Limited posts an Altman Z-Score of -0.70, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -0.70 |